Stimulant Induced Movement Disorders in Attention Deficit Hyperactivity Disorder

被引:5
作者
Nam, Seok-Hyun [1 ]
Lim, Myung Ho [2 ]
Park, Tae Won [1 ,3 ]
机构
[1] Jeonbuk Natl Univ Hosp, Dept Psychiat, Jeonju, South Korea
[2] Dankook Univ, Dept Psychol, Coll Publ Human Resources, Cheonan, South Korea
[3] Jeonbuk Natl Univ, Dept Psychiat, Coll Med, 567 Baekje Daero, Jeonju 54896, South Korea
来源
JOURNAL OF THE KOREAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 2022年 / 33卷 / 02期
关键词
Stimulant; Movement disorders; Attention deficit hyperactivity disorder; Tics; Parkinson's disease; PARKINSONS-DISEASE; DEFICIT/HYPERACTIVITY DISORDER; TOURETTES-SYNDROME; SUBSTANTIA-NIGRA; TIC DISORDERS; METHYLPHENIDATE TREATMENT; FOLLOW-UP; L-DOPA; CHILDREN; ADHD;
D O I
10.5765/jkacap.210034
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Stimulants, such as amphetamine and methylphenidate, are one of the most effective treatment modalities for attention deficit hyperactivity disorder (ADHD) and may cause various movement disorders. This review discusses various movement disorders related to stimulant use in the treatment of ADHD. We reviewed the current knowledge on various movement disorders that may be related to the therapeutic use of stimulants in patients with ADHD. Recent findings suggest that the use of stimulants and the onset/aggravation of tics are more likely to be coincidental In rare cases, stimulants may cause stereotypies, chorea, and dyskinesia, in addition to tics. Some epidemiological studies have suggested that stimulants used for the treatment of ADHD may cause Parkinson's disease (PD) after adulthood. However, there is still a lack of evidence that the use of stimulants in patients with ADHD may cause PD, and related studies are only in the early stages. As stimulants are one of the most commonly used medications in children and adolescents, close observations and studies are necessary to assess the effects of stimulants on various movement disorders, including tic disorders and Parkinson's disease.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 50 条
[31]   Adult Attention Deficit Hyperactivity Disorder in an Anxiety Disorders Population [J].
Van Ameringen, Michael ;
Mancini, Catherine ;
Simpson, William ;
Patterson, Beth .
CNS NEUROSCIENCE & THERAPEUTICS, 2011, 17 (04) :221-226
[32]   Attention-deficit/Hyperactivity Disorder and Sleep Disorders in Children [J].
Tsai, Ming-Horng ;
Huang, Yu-Shu .
MEDICAL CLINICS OF NORTH AMERICA, 2010, 94 (03) :615-+
[33]   Fundamental Movement Skills and Children with Attention-Deficit Hyperactivity Disorder: Peer Comparisons and Stimulant Effects [J].
William J. Harvey ;
Greg Reid ;
Natalie Grizenko ;
Valentin Mbekou ;
Marina Ter-Stepanian ;
Ridha Joober .
Journal of Abnormal Child Psychology, 2007, 35 :871-882
[34]   Updates on Attention-Deficit/Hyperactivity Disorder and Learning Disorders [J].
Semrud-Clikeman, Margaret ;
Bledsoe, Jesse .
CURRENT PSYCHIATRY REPORTS, 2011, 13 (05) :364-373
[35]   Fundamental movement skills and children with attention-deficit hyperactivity disorder: Peer comparisons and stimulant effects [J].
Harvey, William J. ;
Reid, Greg ;
Grizenko, Natalie ;
Mbekou, Valentin ;
Ter-Stepanian, Marina ;
Joober, Ridha .
JOURNAL OF ABNORMAL CHILD PSYCHOLOGY, 2007, 35 (05) :871-882
[36]   Relationship between sleep disorders and attention-deficit-hyperactivity disorder in children [J].
Yin, Huimei ;
Yang, Dong ;
Yang, Lin ;
Wu, Guangsheng .
FRONTIERS IN PEDIATRICS, 2022, 10
[37]   Obstructive Sleep Apnea and Sleep Disorders in Children with Attention Deficit Hyperactivity Disorder [J].
Nguyen-Thi-Phuong, Mai ;
Nguyen-Thi-Thanh, Mai ;
Goldberg, Robert Joel ;
Nguyen, Hoa L. ;
Dao-Thi-Minh, An ;
Duong-Quy, Sy .
PULMONARY THERAPY, 2025,
[38]   Attention deficit hyperactivity disorder [J].
Cunill, Ruth ;
Castells, Xavier .
MEDICINA CLINICA, 2015, 144 (08) :370-375
[39]   Attention Deficit and Hyperactivity Disorder [J].
Fawns, Tina .
PRIMARY CARE, 2021, 48 (03) :475-491
[40]   Safety of stimulant treatment in attention deficit hyperactivity disorder: part I [J].
Merkel, Richard Lawrence, Jr. ;
Kuchibhatla, Ajay .
EXPERT OPINION ON DRUG SAFETY, 2009, 8 (06) :655-668